miDiagnostics and CEO Honored in Business Worldwide's 2026 Global Corporate Excellence Awards
Event summary
- miDiagnostics won 'MedTech Company of the Year – Breakthrough Diagnostic Technology | Europe' at Business Worldwide Magazine's 2026 Global Corporate Excellence Awards.
- CEO Katleen Verleysen received 'Outstanding Leadership in Clinical Molecular Diagnostics | Europe'.
- The company's ultra-fast PCR-based testing technology reduces sterility testing time from days to under two hours for advanced immunotherapies like CAR-T cancer treatments.
- Verleysen has led miDiagnostics' commercial growth and international expansion since joining as CEO in 2021.
The big picture
miDiagnostics' recognition underscores the growing demand for rapid, reliable diagnostics in personalized medicine. As CAR-T therapies and other advanced immunotherapies gain traction, the company's technology addresses critical bottlenecks in treatment delivery. The awards highlight both miDiagnostics' scientific innovation and its strategic positioning within the evolving healthcare landscape.
What we're watching
- Technology Adoption
- How quickly major pharmaceutical companies will integrate miDiagnostics' rapid sterility testing into advanced therapy manufacturing.
- Market Expansion
- Whether miDiagnostics can sustain its international growth trajectory in the competitive life sciences sector.
- Regulatory Compliance
- The pace at which regulatory standards will adapt to support faster diagnostic technologies in personalized medicine.
Related topics